3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Head and Neck Neoplasms
1
Gigantism
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Carcinosarcoma
1
Interventions
pembrolizumab
5
enfortumab vedotin
3
Gemcitabine
3
dodecyl maltoside
2
Sunitinib
2
Cisplatin
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
tucatinib
1
testosterone 17 beta-cypionate
1
temsirolimus
1
relatlimab
1
palbociclib
1
niraparib
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
cabozantinib
1
Valproic Acid
1
Urinary Diversion
1
Trastuzumab
1
Testosterone Propionate
1
Standard of Care
1
Sirolimus
1
Rivaroxaban
1
Ringer's acetate
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Tissue Banks
×
1 year
×
Clear all
No trials found.